Recent News

UNC Lineberger researchers present findings at San Antonio Breast Cancer Symposium

UNC Lineberger researchers present findings at San Antonio Breast Cancer Symposium

UNC Lineberger breast cancer faculty members presented their research findings at the 2016 San Antonio Breast Cancer Symposium Dec. 6-10. The meeting drew more than 7,000 cancer caregivers and scientists from around the world, who attended talks and presentations on the latest developments in breast cancer care and research.

UNC Lineberger researchers present findings at San Antonio Breast Cancer Symposium - Read More…

For invasive breast cancer, researchers identify biomarkers of treatment response

For invasive breast cancer, researchers identify biomarkers of treatment response

UNC Lineberger researchers reported at the San Antonio Breast Cancer Symposium they have identified biomarkers they believe can be used as part of a larger model to predict how patients with HER2-positive operative breast cancer will respond to the targeted treatment trastuzumab, commercially known as Herceptin, and chemotherapy.

For invasive breast cancer, researchers identify biomarkers of treatment response - Read More…

Researchers developing model to predict if chemotherapy will work for aggressive breast cancer

Researchers developing model to predict if chemotherapy will work for aggressive breast cancer

In a study presented at the 2016 San Antonio Breast Cancer Symposium, UNC Lineberger researchers led by Katherine Hoadley, PhD, reported they developed a model that can predict which triple negative breast cancer patients will respond to chemotherapy.

Researchers developing model to predict if chemotherapy will work for aggressive breast cancer - Read More…

Genetic alterations more common in tumors of older patients with metastatic breast cancer

Genetic alterations more common in tumors of older patients with metastatic breast cancer

In preliminary findings presented at the 2016 San Antonio Breast Cancer Symposium, researchers showed that older patients were as likely as younger patients to receive targeted therapy and enroll in therapeutic trials based on their sequencing results.

Genetic alterations more common in tumors of older patients with metastatic breast cancer - Read More…